The management of anaesthesia and outcome of 75 treatments in 52 patients are discussed. Total intravenous anaesthetic techniques were used with venturi ventilation via a rigid bronchoscope. A number of complications occurred, but there was no death or major surgical complication. All complications except one were apparent intraoperatively or in the recovery room. As the considerable risk of intraoperative hypoxia was considered to outweigh the minimal risk of intratracheal fire or explosion, no attempt was made to limit inspired oxygen concentration (F/oJJ during the application of the laser. The results ofventilation/perfusion studies and a recent diagnostic bronchoscopy were very helpful in patient selection.
A carbon dioxide (C02) laser with a wavelength of 10,600 nm and a penetration of 0.1 mm produces a scapel-like incision with coagulation of small vessels. It has been used since 1972 for laryngeal lesions.
The Nd-YAG laser differs in having a wavelength of 1060 nm and a penetration of 4 to 5 mm. It is therefore less useful as a scalpel, but is useful for coagulation of larger lesions. In addition, unlike a C02 laser, it can be transmitted by a single quartz fibre of 200-600 microns and can be used endoscopically. It has been used since the late 1970s for treating benign and malignant gastrointestinal and lower respiratory tract lesions.
At Peter MacCallum Cancer Institute we have been using an Nd-YAG laser since October 1986 for palliation of bronchial obstruction, haemoptysis and less commonly for intractable cough. Prior to the introduction of the Nd-YAG laser, emergency bronchoscopic debulking of tumours was often associated with massive haemoptysis and intraoperative hypoxia and was thus rarely attempted. This is a report of the experience with anaesthesia for the first 52 patients (75 treatments). The surgical aspects of our first twelve months' experience, in which 31 Type of lesion primary bronchogenic carcinoma secondary carcinoma 
PATIENTS AND METHODS
From October 1986 to June 1988 52 patients (40 males, 12 females) with an age range from 29 to 80 years (mean age 66 years) received 75 treatments for endobronchial lesions by means of an N d-Y AG laser. Eleven of these patients required from one to six subsequent treatments.
The lesions treated are listed in Table 1 . The sites of the lesions treated are illustrated below in Figure 1 .
The major indication for treatment in 47 of the 52 patients was dyspnoea due to significant endobronchial obstruction. Other indications were haemoptysis, intractable cough, stridor and wheeze. Some patients had more than one indication. Initially only patients in whom other methods of treatment had failed were accepted. But as laser resection proved to be a relatively rapid and safe treatment, the policy was changed to laser of the tracheobronchial component of the tumour first, and subsequent radiotherapy or chemotherapy. When there was a recurrence after a satisfactory initial treatment, further laser resection was performed.
Major contraindications were when the airway compression was predominantly extrinsic, superior venal caval obstruction and long-standing obstruction of a main bronchus associated with neither ventilation nor perfusion to that lung. Metastatic disease was not necessarily a contraindication if dyspnoea, haemoptysis or cough were incapacitating symptoms.
PREOPERA TIVE ASSESSMENT
Patients were assessed preoperatively with a standard medical history and examination. Preoperative investigations included chest X-ray, ECG, biochemistry and haematology plus respiratory function tests, ventilation perfusion (v/Q) scans, and CT scans and blood gas analysis when indicated.
The majority of patients had had a recent diagnostic bronchoscopy, usually under general anaesthesia, performed at Peter MacCallum Cancer Institute. This proved to be important in patient selection as on several occasions when a bronchoscopy report from elsewhere was accepted we found we were dealing with extrinsic airway compression which cannot be treated by laser.
Surgical technique
The laser treatments were administered with a Cooper Laseronics model 8000 Nd-YAG Laser. The laser fibre was passed down either a rigid Shapsay-Storz bronchoscope 5 or a fibreoptic bronchoscope. A Shapsay-Storz bronchoscope is a rigid bronchoscope modified for laser surgery. It has two additional channels, one for the laser fibre, the other for additional suction to remove the smoke and other vapours. A fibreoptic bronchoscope passed down the rigid scope was used on occasions to perform additional bronchial toilet or to direct the laser beam into the upper bronchi.
Anaesthetic technique
All patients were given a broad spectrum intravenous antibiotic cover to minimise the risk of sepsis after clearing a major bronchus that had been occluded for some time. Dexamethasone 8 mg IM was given in an attempt to minimise the oedema consequent on prolonged endobronchial manipulation. Atropine was not given routinely. Initially, particularly when using a ketamine infusion, patients were also given oral diazepam or droperidol preoperatively but this was soon abandoned as it was found to prolong the recovery period.
Anaesthesia was induced with either fentanyl and methohexitone or ketamine preceded by diazepam or midazolam. When the ability to ventilate with a face mask was confirmed, suxamethonium was given, the cords were sprayed with lignocaine 4%/4 ml and intubation was performed with the rigid bronchoscope.
Anaesthesia was maintained with a ketamine 2 or methohexitone infusion 204 with an Oximetrix pump or a Terumo STC-521 syringe driver. When using methohexitone a plasma concentration of 4-5 mg/l was aimed at. 4 Muscle relaxation was maintained with intermittent suxamethonium when a very short treatment was anticipated but most frequently with alcuronium or vecuronium, and the patients were ventilated with an oxygen-driven venturi Bronchoflator model BF-R via the bronchoscope. 5 They were monitored with standard ECG, non-invasive automatic oscillometric blood pressure (Dinamap), clinical assessment of chest movement and oximetry using an Ohmeda 3700 pulse oximeter.
At the end of the procedure neuromuscular block was reversed when necessary with neostigmine and atropine, and patients were extubated when they appeared able to cough and breathe adequately.
All patients received humidified oxygen with an FI02 of 0.4 postoperatively until the next morning. Chest physiotherapy which had been given preoperatively was continued in the recovery room and at least once after return to the ward. Antibiotics and steroids were continued as indicated. 
Patient profile and ASA status
In addition to the lesion being treated many patients had other medical problems. Most had chronic obstructive airways disease in addition to their major airway obstruction. Five patients were severely dyspnoeic and two dependent on oxygen at rest. A number had pneumonia, and one patient a lung abscess, distal to an obstructed airway. Many patients also had controlled hypertension and/or ischaemic heart disease and some had arrhythmias, most commonly controlled atrial fibrillation. Four patients had diabetes mellitus, sometimes steroid-precipitated, while a further four with lung carcinoma had known metastatic disease. Table 2 shows the ASA status of the group. The ASA 1 patient was 47 years old and had a benign tracheal web. Two Of the ASA 4 patients were severely dyspnoeic and dependent on oxygen at rest. The other ASA 4 patient had controlled atrial fibrillation, right main bronchus obstruction and resolving superior vena cava obstruction. He was severely dyspnoeic at rest, but was relatively young and very keen to be treated. His case appears later as a major complication. An additional three cases were cancelled after anaesthetic assessment. They were very ill patients in whom only minimal benefit could realistically be expected.
RESULTS Treatment times ranged from 20 to 90 minutes but with experience this rarely exceeded 45 minutes. These times compare with reported treatment times varying from ten minutes 6 up to 240 minutes. 7 A major factor in this variation is probably patient selection.
Postoperatively the majority of patients were able to be extubated within five minutes of the end of the procedure, the majority being awake and able to co-operate with chest physiotherapy after fifteen minutes in the recovery room. Brisk recovery was particularly noticeable after we abandoned preoperative sedation.
Seventy-five per cent of the patients with malignancy were assessed as deriving good or total initial relief of symptoms,l and frequently were well enough for discharge the next day. That this treatment is palliative only is highlighted by the fact that many of these patients have subsequently died and by the need for retreatment of eleven of these patients after periods varying from four weeks to over six months. One patient required treatment seven times over fourteen months and enjoyed a good quality of life between treatments.
It became apparent that patients in whom obstructing endobronchial tumour recurred after laser resections rarely became symptomatic until the situation was critical. Therefore, rather than wait for the patient to present again with acute dyspnoea, we instituted regular bronchoscopic review under general anaesthesia with the possibility of further laser resection if required. The time interval between bronchoscopic review varied from four weeks to three months and was determined by the apparent clinical characteristics of the tumour. Laser treatment, unlike radiotherapy or chemotherapy, has no maximal dose.
The two patients with benign disease had total and, to date, lasting relief of their symptoms.
Complications
A significant number of perioperative complications occurred (Table 3) , but there were no deaths or instances of bronchial perforation or pneumothorax. Intraoperative complications were mainly cardiovascular or ventilation and/or hypoxia related. One patient developed rapid atrial fibrillation on four occasions. He had a history of ischaemic heart disease and we assumed on the first occasion that the fibrillation had been precipitated by hypertension associated with the use of a ketamine infusion. However using a methohexitone infusion with a maximum systolic blood pressure of 150 mmHg, he again developed rapid intraoperative atrial fibrillation despite prophylactic digitalisation prior to treatments 3 and 4.
Three of the cases of intra operative hypoxia were associated with haemorrhage, in one case greater than 250 ml, but in all cases this was able to be controlled. The other two were associated with bronchial obstruction due to fibre optic bronchoscopy in difficult attempts to clear upper lobes and responded rapidly to removing the fibreoptic bronchoscope and pulling the rigid scope back to the carina.
The patient who could not be ventilated with a mask presented an unexpected complication. He had had a pneumonectomy with stump recurrence for which he had received maximal radiotherapy. He had had two previous uncomplicated laser resections. However, because of his rapidly recurring tumour, he was being followed by monthly review bronchoscopies. This time he had an unexpected and totally asymptomatic recurrence just below his cords. An airway was established with the rigid bronchoscope and successful laser treatment was proceeded with.
The patient whom we were unable to ventilate (twice) with a venturi at maximum Anaesthesia and Intensive Care. Vol. 18, No. 1. February, 1990 pressure ( 400 kPa) was 120 kg and had severe tracheal obstruction. He was able to be ventilated with a face mask and the procedure was abandoned. He had received a course of radiotherapy between the two attempts but had not responded.
Four patients needed to be re-intubated either with a bronchoscope or endotracheal tube to enable additional suction or shortterm ventilation. Two patients were transferred to an intensive care unit for longer-term ventilation. The first patient developed a recurrence of superior vena cava obstruction and gross laryngeal oedema requiring emergency tracheostomy after prolonged laser treatment. (We now regard obstruction of the superior vena cava as an absolute contraindication to laser treatment.) The second patient was slow to breathe and was ventilated overnight.
All complications except one were apparent either intraoperatively or in the recovery room. The late complication of pneumonia and possible septicaemia developed on the night of surgery, but responded rapidly to the addition of metronidazole and gentamicin to the antibiotic regimem.
DISCUSSION
Published perioperative mortality rates vary widely from 0 to 9.1%. 7, 10, 14, 15 This vanatlOn is probably related to lack of precision in reporting as no definitions are included apart from intraoperative deaths, but may also relate to patient selection or an enthusiasm for attempting to clear totally obstructed major bronchi. In the absence of identifiable landmarks, particularly the direction of the airway, and with the inability to assess the extent of intrinsic tumour, laser treatment must be very slow and meticulous if a high incidence of perforation or major haemorrhage is to be avoided.
Only patients likely to benefit should be subjected to laser surgery. We feel that a recent bronchoscopy, preferably by the surgeon who will be doing the laser, is vital, as is early referral for patients who develop major airway obstruction and distal lung collapse. Our vii:) studies showed that in longstanding brochial obstruction it was almost impossible to restore perfusion to the lung in which perfusion was minimal, even though some of these patients appeared to benefit subjectively from the procedure. Thus longstanding obstruction with neither ventilation nor perfusion should be a contraindication.
Since it is the anaesthetists who are faced with detecting and managing most of the common, and at times life-threatening complications, it is important that they play an active role in patient selection. To do this they must have a good knowledge of laser surgery, and a good working relationship with the surgeon.
Three anaesthetic techniques have been described for laser bronchoscopy. 1. Local anaesthesia with or without sedation, generally with a fibreoptic bronchoscope. 8 • 1O 2. General anaesthesia with spontaneous ventilation using either a rigid 6 ,11 or flexible bronchoscope. 7 ,12 3. General anaesthesia and controlled ventilation with either an intubated patient and a flexible bronchoscope 13 or venturi ventilation via a rigid scope. 9 ,10,12,14.16 Although local anaesthesia with or without sedation using a flexible scope is superficially appealing, we rejected this in light of the UCH experience. 8 ,9,14 They reported that few patients are able to tolerate' a relatively prolonged procedure without coughing, gagging or becoming restless, all of which may increase the risk of complications, particularly haemorrhage, perforation and pneumothorax. In addition this technique severely limits the surgeon's view and the size of the forceps and suckers that can be used, hence further prolonging the procedure.
Many of the UCH patients treated initially with this technique required a second or third treatment to clear the obstruction, and two intraoperative deaths from hypoxia secondary to major haemorrhage in semi-sedated patients were reported.
We chose to use total intravenous anaesthesia and venturi ventilation. Our contraindications to using a ketamine infusion were hypertension, past history of haemorrhagic stroke and patients in whom the risks of hypertension or tachycardia were considered to outweigh the advantages of the drug. Although some patients, for instance the patient who received seven treatments over fourteen months, did very well with ketamine, this was used relatively infrequently.
With increasing experience, treatment times became shorter and methohexitone was generally found to be preferable. (Propofol was not available for this series, but has been used since with good results.)
Many overseas centres stress that the risk of intratracheal fire or explosion is increased by using a high FI02 and recommend using the lowest possible FI02. Levels recommended vary from 0.21 in nitrogen (i.e. air) to 0.5 in nitrogen. 13, 15 Nitrous oxide (N20) is stated to support combustion as readily as oxygen, hence reducing the FI02 and replacing it with N 20 is of no value in reducing the risk of fire or explosion. 18, 21 We, however, made no attempt to limit FI02 as we used a Bronchoflator driven by oxygen. We and others 9 ,11,13,2o consider that the major risk is intraoperative hypoxia due to a number of factors including preoperative lung disease, haemorrhage or secretions in a shared airway and reduction of the shared airway by surgical instrumentation, particularly when a fibreoptic bronchoscope is used in one main bronchus. This risk clearly increases with a low FI02.
Severe intraoperative hypoxia was rare in our series. Early detection using the pulse oximeter enabled us to prevent it or control its severity. An oximeter is mandatory due to the rapid fluctuations that can occur in oxygen saturation (Sao2) plus the difficulty of assessing colour due to the need to wear greentinted protective eye goggles. Lennon et a/. 20 compared percutaneous oxygen and carbon dioxide monitors with an oximeter and arterial blood gases. They found that Sao2 monitoring was the most reliable available monitor.
We think that the risk of intratracheal fire or explosion has been exaggerated, and consider this risk to be minimal with scrupulous surgical technique, i.e. scupulous attention to the removal of dead tissue and to keeping the Y AG fibre tip clean and flushed. This view appears to be supported by the fact that only one intratracheal fire has been reported with a Nd-YAG laser I7 , as compared with frequent reports with a C02 laser. This was when a fibreoptic bronchoscope with a plastic sheath, and a PVC endotracheal tube were used, resulting in two flammable pieces of equipment. All plastic and rubber endotracheal tubes are flammable, and wrapping the endotracheal tube with metal foil tape offers no protection against damage from an Nd-YAG laser l7 • 19 as opposed to the C02 laser. Hence, endotracheal tubes are best avoided.
Although laser bronchoscopy is generally a palliative procedure it can give a very worthwhile improvement in quality oflife and lifespan. A number of patients submitted to laser bronchoscopy would be classified as unfit for anaesthesia if presented for other forms of surgery. Anaesthetists play a significant role and this should include being active in patient selection. ACKNOWLEDGEMENT
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